Thymosin Beta 4 (TB500)

Thymosin Beta 4 (TB500) is a synthetic analog of the endogenous protein thymosin beta-4, a highly conserved actin-sequestering peptide found in virtually all animal cells. Its molecular structure consists of 43 amino acids, contributing to a molecular weight of 4963.44 g/mol. The peptide's primary sequence is Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser. Research into TB500 has historically explored its involvement in actin dynamics, a fundamental process in cellular motility and structural integrity. Biochemically, TB500 is recognized for its capacity to bind to G-actin, thereby inhibiting its polymerization into F-actin. This interaction is crucial for regulating the cellular cytoskeleton and is implicated in various cellular functions, including cell migration, angiogenesis, and extracellular matrix remodeling. Investigations have also examined its potential influence on stem cell differentiation and proliferation in in vitro models. Laboratory research applications for TB500 include studies on cellular regeneration pathways, examination of its effects on tissue repair mechanisms at a molecular level, and exploration of its interactions with various cellular components. Researchers utilize TB500 to elucidate the complex signaling cascades involved in wound healing and tissue development, providing insights into fundamental biological processes.